OQS
CLB icon

Occudo Quantitative Strategies’s Core Laboratories CLB Stock Holding History

Occudo Quantitative Strategies’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-27,304
Closed -$609K – 1150
2021
Q4 		$609K Sell
27,304
-13,431
-33% -$350K 0.05% 549
2021
Q3 		$1.13M Buy
+40,735
New +$1.24M 0.14% 235
2021
Q1 		– Sell
-13,477
Closed -$357K – 777
2020
Q4 		$357K Buy
+13,477
New +$275K 0.11% 350

Other funds holding CLB

AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
CPH
C Partners Holding Zurich, Switzerland $317M AUM 4.76% 1-Year Est. Return

Occudo Quantitative Strategies's CLB Position: Q1 2022 in Review

Occudo Quantitative Strategies sold out of Core Laboratories (CLB) in Q1 2022, closing a stake of 27,304 shares — an estimated $609K sold.

Occudo Quantitative Strategies first reported a position in CLB in Q4 2020 and held it in 3 quarters. The position peaked at $1.13M in Q3 2021. 196 funds tracked by Wall St. Rank hold CLB as of Q1 2022.

  • Occudo Quantitative Strategies reported no remaining Core Laboratories position as of Q1 2022 after selling out during the quarter.
  • Occudo Quantitative Strategies sold 27,304 Core Laboratories shares in Q1 2022, an estimated $609K.
  • Occudo Quantitative Strategies first reported a position in Core Laboratories in Q4 2020 and held it in 3 quarters.
  • Occudo Quantitative Strategies's Core Laboratories position peaked at $1.13M in Q3 2021.
  • 196 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2022.

Based on Occudo Quantitative Strategies's 13F filing for Q1 2022, filed 16 May 2022.